Members,
On what was an otherwise bloody day on Wall Street, stocks in the cannabis sector saw major gains.
Our mega-winner from December 18th, THCZ, closed the day up another +18% on heavy trading volume.
THCZ has now moved from our original alert price of $0.0095 to a new 52-week high of $0.072 per share today for an incredible +657.89% gain over the last 3 months.
This is just one example of how the cannabis industry has been an absolute goldmine for us.
For our next trade idea, we are sticking with this sector and alerting a red-hot subpenny on the verge of a massive breakout.
Immediately turn your attention to PZOO (Pazoo, Inc.).
Some of you may already be familiar with this company, as it has delivered serious gains for us twice before.
Currently trading for just under a penny, PZOO appears ready for yet another profitable run up the chart.
PZOO is a company focused on empowering individuals with the tools to enrich their lives. Pazoo delivers information, services and products through direct response digital and TV, retail stores and its website. www.pazoo.com is a health and wellness online portal with an array of experts delivering vital information to improve and enhance the enjoyment of living a full and enriching life. They feature industry experts from the health and wellness industry as well as the pet industry. On their website an individual can find a limited, and high quality, selection of merchandise, including fitness consumables, nutritional supplements, apparel, and wellness/safety products.
PZOO reported a very impressive 125% increase in web traffic, and expects even more growth as they continue to optimize their web presence.
The Company intends to generate traffic for its website to not only inform people, but also to drive users towards its e-commerce platforms. The Company has employed a state of the art technological platform to geo target users and is using social media platforms such as Facebook and Twitter to drive traffic to the website. Experienced marketing professionals are customizing the website to ensure maximum hits and sales. Negotiating with new partners to build a strong network of goods and shipping companies has resulted in higher profit margins for the Company.
Web traffic is imperative to PZOO, and as more and more consumers visit their site, we expect a dramatic increase in sales revenue in the quarters ahead.
PZOO's second business model is its 40% shareholding in MA & Associates (MA), a state of the art testing medical cannabis testing facility in Nevada. This entry into the field of pharmaceutical testing of cannabis is a massive corporate home run. By acquiring its stake in MA and Associates, Pazoo has established a strong foothold in the field of cannabis testing.
MA and Associates received its license on November 3, 2014 and was rated as the top testing lab applicant licensed by the state of Nevada. It is the only certified testing facility in Nevada. Stringent Nevada laws on cannabis decree strict testing for impurities and compounds found in cannabis. This means that all growers of industrial hemp and medical cannabis in the state of Nevada are potential customers of MA and Associates. Pazoo also has expansion plans for other states in the U.S. and Canada, both being countries with burgeoning medical markets.
MA and Associates is strategically focused on securing relationships with a multitude of growers within the State of Nevada. Recently, MA has received its first purchase order to test product from one of the largest growers in the State of Nevada. The grower, whose name is kept confidential, has approximately 155,000 square feet of growing resulting in a revenue potential of over $ 1.5 million per annum. MA & Associates is targeting to enter into relationships with growers representing 500,000 square feet of grow. Such relationships shall help the Company to secure a solid and expanding revenue stream.
While this initial purchase order is for a few thousand dollars, it will serve as a quality test for their client. MA is 100% confident that they will not only meet but exceed the standards their clients expect. This is the beginning of a very important relationship with one of the largest growers in the State of Nevada. This grower, which has requested its name remain confidential, will represent approximately 200,000 square feet of growing. MA's management team has estimated that every 100,000 square feet of grow that is tested will translate into approximately $1,000,000 of revenue per calendar year. To date, MA feels confident that it has forged working relationships with additional growers who will test through MA and who will represent approximately another 500,000 square feet of grow.
In January MA & Associates, received all of the necessary building permits and approvals to begin the final phase of the build-out of its facility in Las Vegas. More than $100,000 was advanced for this construction phase which will include a state of the art electrical and security system.
The facility is expected to be fully completed, with machinery in place and ready to be operational, by the beginning to middle of April, there will be a ceremonial grand opening on the infamous date of 4/20 (April, 20, 2015). It is expected that growers will be delivering their first product to be tested on or before the end of April this year.
Antonio Del Hierro, Co-CEO of Pazoo stated, "The next few months are going to be a very exciting time for Pazoo and its shareholders as we will be transitioning into a company that is expected to experience a very high rate of growth. We are also very excited and have very high expectations for expansion in the very near future into several other states with our wholly-owned subsidiary Harris Lee, LLC."
"We are very excited about how we are currently positioned in the marijuana testing industry," stated Pazoo CEO David Cunic. "The combination of MA & Associates, LLC within Nevada, along with Harris Lee, LLC outside Nevada, gives Pazoo the ability to focus solely on providing the most comprehensive testing criterion available, benefiting both growers and dispensaries."
Market Outlook
The support for legalization of cannabis is growing, and patients and doctors are looking at medical cannabis as an alternative source of medicine. Through its collaborations with MA & Associates and Harris Lee, LLC, the Company is building a strong footprint in the currently fragmented but highly profitable testing business, ancillary to growing and supplying cannabis. MA & Associates is strategically focusing on securing relationships with a multitude of growers within the State of Nevada with a view to secure a solid and expanding revenue stream.
Two weeks ago, Alaska became the 3rd state following Washington and Colorado to officially legalize marijuana.
Twenty-three states and the District of Columbia currently have laws legalizing marijuana in some form and legalization is expected to sweep the nation in the years to come out.
If all 50 states legalized marijuana and the federal government ended prohibition of the plant, the marijuana industry in the United States would be worth $35 billion just six years from now.
That's according to a new report from GreenWave Advisors, a research and advisory firm that serves the emerging marijuana industry in the U.S., which found that if all 50 states and the federal government legalized cannabis, combined sales for both medical and retail marijuana could balloon to $35 billion a year by 2020.
If the federal government doesn't end prohibition and the trajectory of state legalization continues on its current path, with more, but not all, states legalizing marijuana in some form, the industry in 2020 would still be worth $21 billion, GreenWave projects.
In its $21 billion 2020 model, GreenWave predicts 12 states plus the District of Columbia to have legalized recreational marijuana (besides Colorado and Washington, which legalized it in 2012). Those states are: Alaska, Arizona, California, Hawaii, Maine, Maryland, Massachusetts, Nevada, New Hampshire, Oregon, Rhode Island and Vermont.
By that same year, the model assumes, 37 states will have legalized medical marijuana. To date, 23 states and the District of Columbia have legalized marijuana for medical use.
The good news is that we may not have to wait until 2020 for the retail marijuana market to hit $35 billion.
Just a few weeks ago, Rep. Jared Polis (D-Colo.) and Rep. Earl Blumenauer (D.Ore.) introduced two bills that would essentially legalize, regulate and tax marijuana at the federal level and thus ending the U.S. government’s prohibition of the plant.
With the growing support for legalization of medical cannabis in the United States, PZOO can become the go-to company for the testing of cannabis related products.
Wall St. appears to be bullish on the cannabis sector once again.
Today PZOO closed at its high-of-day price, setting up huge momentum heading into tomorrow's trading session.
With a tiny float of just 132.1M, a slight burst of volume could send PZOO shares through the roof!
Remember, PZOO has been a winner for us twice before.
Tomorrow is shaping up to be PZOO's biggest day yet, and we want everyone to be a part of it.
We are urging our members to add PZOO to the top of your watchlist immediately, and be prepared to trade this subpenny gem tomorrow at 9:30am EST.
To learn more about PZOO, please visit their website: www.Pazoo.com
